An open-label trial of acamprosate in the treatment of pathological gambling

Annals of Clinical Psychiatry

Volumn 23, Issue 4, 2011, Pages 250-256

  Black, Donald W ^a   McNeilly, Dennis P ^b   Burke, William J ^b   Shaw, Martha C ^a   Allen, Jeff ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acamprosate; Impulse control disorders; Pathological gambling

Indexed keywords

ACAMPROSATE; DRUG DERIVATIVE; PSYCHOTROPIC AGENT; TAURINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMMON COLD; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV-TR; FEMALE; FLATULENCE; FOLLOW UP; GAMBLING SEVERITY ASSESSMENT SCALE; HAMILTON SCALE; HUMAN; IMPULSE CONTROL DISORDER; MALE; OUTCOME ASSESSMENT; PATHOLOGICAL GAMBLING; PATIENT ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SELF RATED GLOBAL SCALE; SHEEHAN DISABILITY SCALE; SOMNOLENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TIMELINE FOLLOW BACK; TREATMENT INDICATION; VITAL SIGN; YALE BROWN OBSESSIVE COMPULSIVE SCALE MODIFIED; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

FEMALE; GAMBLING; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; TAURINE; TREATMENT OUTCOME;

EID: 84858314840     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gambling Impact and Behavior Study. Chicago, IL: National Opinion Research Center at the University of Chicago (NORC); 1999.
2. Shaw MC, Forbush KT, Schlinder J, et al. The effect of pathological gambling on families, marriages, and children. CNS Spectr. 2007;12:615-622. (Pubitemid 47329498)
3. Politzer R, Yesalis C, Hudak C. The epidemiologic model and the risk of legalized gambling: where are we headed? Health Values. 1992;16:20-27.
4. Black DW, Shaw MC. Psychiatric comorbidity associated with pathological gambling. Psychiatric Times. 2008;25:14-18.
5. Shaffer HJ, Korn DA. Gambling and related mental disorders: a public health analysis. Annu Rev Public Health. 2002;23:171-212. (Pubitemid 34508072)
6. Cunningham JA. Little use of treatment among problem gamblers. Psychiatr Serv. 2005;56:1024-1025. (Pubitemid 41098751)
7. Ladouceur R, Sylvain C, Boutin C, et al. Cognitive treatment of pathological gambling. J Nerv Ment Dis. 2001;189:774-780. (Pubitemid 33095527)
8. Petry NM. Psychosocial treatments for pathological gamblers. Psychiatric Annals. 2002;32:192-196.
9. Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49:914-921. (Pubitemid 32493813)
10. Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006;163:303-312. (Pubitemid 44480852)
11. Kim SW, Grant JE, Adson DE, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:501-507. (Pubitemid 34680358)
12. Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol. 2003;18:243-249. (Pubitemid 36871876)
13. Hollander E, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry. 2000;47:813-817. (Pubitemid 30254054)
14. Blanco C, Petkova E, Ibáñez A, et al. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry. 2002;14:9-15. (Pubitemid 34538827)
15. Black DW. An open-label trial of bupropion in the treatment of pathologic gambling. J Clin Psychopharmacol. 2004;24:108-110. (Pubitemid 38134183)
16. Pallanti S, Baldini Rossi N, Sood E, et al. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry. 2002; 63:1034-1039. (Pubitemid 35388064)
17. Zimmerman M, Breen RB, Posternak MA. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:44-48. (Pubitemid 34113486)
18. Black DW, Shaw M, Forbush KT, et al. An open-label trial of escitalopram in the treatment of pathological gambling. Clin Neuropharmacol. 2007;30:206-212. (Pubitemid 47356717)
19. Black DW, Arndt S, Coryell WH, et al. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol. 2007;27:143-150. (Pubitemid 46594929)
20. Dannon PN, Lowengrub K, Musin E, et al. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol. 2005;25:593-596. (Pubitemid 41669057)
21. Hollander E, Pallanti S, Allen A, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162:137-145. (Pubitemid 40095683)
22. Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002;63:559-564. (Pubitemid 34787319)
23. Dannon PN, Lowengrub K, Gonopolski Y, et al. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol. 2005;28:6-10. (Pubitemid 40269711)
24. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1191-1194.
25. De Witte P, Littleton J, Parot P, et al. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs. 2005;19:517-537. (Pubitemid 41058377)
26. Shaffer HJ, LaPlante DA, LaBrie RA, et al. Toward a syndrome model of addiction: multiple expressions, common etiology. Harv Rev Psychiatry. 2004;12:367-374. (Pubitemid 40144222)
27. Wray I, Dickerson MG. Cessation of high frequency gambling and "withdrawal" symptoms. Br J Addict. 1981;76:401-405. (Pubitemid 12253583)
28. Diagnostic and statistical manual of mental disorders, 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
29. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987;144:1184-1188. (Pubitemid 17147523)
30. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis I DSM-IV Disorders - Patient Edition (SCID-I/P). New York: Biometrics Research Department, NY State Psychiatric Institute: 1995.
31. Pfohl B, Zimmerman M, Blum N. A Structured Interview for DSM-IV Personality (SIDP-IV). Washington, DC: American Psychiatric Press; 1997.
32. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
33. Pallanti S, DeCaria CM, Grant JE, et al. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005;21:431-443. (Pubitemid 41713089)
34. Guy W. ECDEU assessment manual for psychopharmacology-Revised (DHEW Publ No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
35. Sheehan DV. The anxiety disease. New York, NY: Bantam Books, Inc.; 1986.
36. Barkley RA. Attention-deficit hyperactivity disorder: handbook for diagnosis and treatment. New York, NY: Guilford Press; 1990.
37. Sobell LC. Alcohol timeline followback user's manual. Toronto, Canada: Addiction Research Foundation; 1995.
38. SAS Institute Inc., SAS/STAT. 9.1 Users Guide. Cary, NC: SAS Institute, Inc.; 2004.
39. Blaszczynski A, McConaghy N, Frankova A. Control versus abstinence in the treatment of pathological gambling: a two to nine year follow-up. Br J Addict. 1991;86:299-306.